Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of Aβ1-42-Induced Alzheimer's Disease Model Rats

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Zhang, Jun ^a,b   Ke, Kai Fu ^b   Liu, Zhan ^a   Qiu, Yi Hua ^a   Peng, Yu Ping ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 17; INTERLEUKIN 22; NEURON SPECIFIC NUCLEAR PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLUORESCENCE HISTOCHEMISTRY; GENE EXPRESSION; GLIOSIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LYMPHOCYTIC INFILTRATION; MALE; MAZE TEST; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NICK END LABELING; NISSL STAINING; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RAT; TH17 CELL; UPREGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; FEMALE; INTERLEUKIN-17; INTERLEUKINS; MALE; NEURODEGENERATIVE DISEASES; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; TH17 CELLS;

EID: 84885038745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075786     Document Type: Article

References (30)

1. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741.
2. Higuchi M, Hatta K, Honma T, Hitomi YH, Kambayashi Y, et al. (2010) Association between altered systemic inflammatory interleukin-1beta and natural killer cell activity and subsequently agitation in patients with Alzheimer disease. Int J Geriatr Psychiatry 25: 604-611.
3. Passos GF, Figueiredo CP, Prediger RD, Silva KA, Siqueira JM, et al. (2010) Involvement of phosphoinositide 3-kinase gamma in the neuro-inflammatory response and cognitive impairments induced by beta-amyloid 1-40 peptide in mice. Brain Behav Immun 24: 493-501.
4. Hardy J, Selkoe DJ, (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
5. Gandy S, Greengard P, (1994) Processing of Alzheimer A beta-amyloid precursor protein: cell biology, regulation, and role in Alzheimer disease. Int Rev Neurobiol 36: 29-50.
6. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421.
7. Heneka MT, O'Banion MK, Terwel D, Kummer MP, (2010) Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 117: 919-947.
8. Agostinho P, Cunha RA, Oliveira C, (2010) Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des 16: 2766-2778.
9. Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, et al. (2002) Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol 124: 83-92.
10. Town T, Tan J, Flavell RA, Mullan M, (2005) T-cells in Alzheimer's disease. Neuromolecular Med 7: 255-264.
11. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
12. Korn T, Bettelli E, Gao W, Awasthi A, Jager A, et al. (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487.
13. Miossec P, Korn T, Kuchroo VK, (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361: 888-898.
14. Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, et al. (2011) Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease. Brain Behav Immun 25: 539-547.
15. Tzartos JS, Craner MJ, Friese MA, Jakobsen KB, Newcombe J, et al. (2011) IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain. Am J Pathol 178: 794-802.
16. Appel SH, Beers DR, Henkel JS, (2010) T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol 31: 7-17.
17. Nagata S, Golstein P, (1995) The Fas death factor. Science 267: 1449-1456.
18. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW, (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13: 1676-1687.
19. Giuffrida ML, Grasso G, Ruvo M, Pedone C, Saporito A, et al. (2007) Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity. J Neurosci Res 85: 623-633.
20. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates. Amsterdam; Boston: Elsevier Academic Press.
21. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
22. Cavaglia M, Dombrowski SM, Drazba J, Vasanji A, Bokesch PM, et al. (2001) Regional variation in brain capillary density and vascular response to ischemia. Brain Res 910: 81-93.
23. McDonald MP, Dahl EE, Overmier JB, Mantyh P, Cleary J, (1994) Effects of an exogenous beta-amyloid peptide on retention for spatial learning. Behav Neural Biol 62: 60-67.
24. Iqbal K, Grundke-Iqbal I, (2005) Pharmacological approaches of neurofibrillary degeneration. Curr Alzheimer Res 2: 335-341.
25. McLarnon JG, Ryu JK, (2008) Relevance of Aβ1-42 intrahippocampal injection as an animal model of inflamed Alzheimer's disease brain. Curr Alzheimer Res 5: 475-480.
26. Farkas IG, Czigner A, Farkas E, Dobo E, Soos K, et al. (2003) Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain. Acta Histochem 105: 115-125.
27. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, et al. (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13: 1173-1175.
28. Beer R, Franz G, Schopf M, Reindl M, Zelger B, et al. (2000) Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab 20: 669-677.
29. Fang Y, Yu S, Ellis JS, Sharav T, Braley-Mullen H, (2010) Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis. J Leukoc Biol 87: 1019-1028.
30. Guicciardi ME, Gores GJ, (2009) Life and death by death receptors. FASEB J 23: 1625-1637.